Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression

Small GTPases

Volumn 3, Issue 1, 2012, Pages

  Bourguignon, Lilly Y W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD44; Cytoskeleton; Hyaluronan; miRNAs; RhoGTPases; Tumor progression

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; HERMES ANTIGEN; HOXD10 PROTEIN; HYALURONIC ACID; MICRORNA; MICRORNA 10B; MICRORNA 21; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC PROTEIN; STAT3 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL SURVIVAL; CYTOSKELETON; ENZYME ACTIVATION; HUMAN; METASTASIS; MOLECULAR PATHOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR RESISTANCE; DRUG RESISTANCE; HEAD AND NECK TUMOR; METABOLISM; NOTE; SQUAMOUS CELL CARCINOMA;

ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; DRUG RESISTANCE, NEOPLASM; HEAD AND NECK NEOPLASMS; HOMEODOMAIN PROTEINS; HUMANS; HYALURONIC ACID; MICRORNAS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84859056774     PISSN: 21541248     EISSN: 21541256     Source Type: Journal    
DOI: 10.4161/sgtp.3.1.19110     Document Type: Article

References (30)

1. Parker B, Sukumar S. Distant metastasis in breast cancer: molecular mechanisms and therapeutic targets. Cancer Biol Ther 2003; 2:14-21; PMID:12673112
2. Kramer RH, Shen X, Zhou H. Tumor cell invasion and survival in head and neck cancer. Cancer Metastasis Rev 2005; 24:35-45; PMID:15785871; http://dx.doi.org/10.1007/s10555-005-5046-2
3. Lee JY, Spicer AP. Hyaluronan: A multifunctional, megaDalton, stealth molecule. Curr Opin Cell Biol 2000; 12:581-586; PMID:10978893; http://dx.doi.org/10.1016/S0955-0674(00)00135-6
4. Stern R, Jedrzejas MJ. Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev 2006; 106:818-839; PMID:16522010; http://dx.doi.org/10.1021/cr050247k
5. Toole BP, Wight TN, Tammi MI. Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 2002; 277:4593-4596; PMID:11717318; http://dx.doi.org/10.1074/jbc.R100039200
6. Bourguignon LY. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin Cancer Biol 2008; 18:251-259; PMID:18450475; http://dx.doi.org/10.1016/j.semcancer.2008.03.007
7. Wang SJ, Bourguignon LY. Role of hyaluronanmediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Am J Pathol 2011; 178:956-963; PMID:21356346; http://dx.doi.org/10.1016/j.ajpath.2010.11.077
8. Jackson DG, Prevo R, Clasper S, Banerji S. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 2001; 22:317-321; PMID:11377291; http://dx.doi.org/10.1016/S1471-4906(01)01936-6
9. Maxwell CA, McCarthy J, Turley E. Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?. J Cell Sci 2008; 121:925-932; PMID: 18354082; http://dx.doi.org/10.1242/jcs.022038
10. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998; 279:509-514; PMID:9438836; http://dx.doi.org/10.1126/science.279.5350.509
11. Wu D, Asiedu M, Wei Q. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC. Oncogene 2009; 28:2219-2230; PMID:19421144; http://dx.doi.org/10.1038/onc.2009.96
12. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996; 273:245-248; PMID:8662509; http://dx.doi.org/10.1126/science.273.5272.245
13. Bourguignon LYW, Zhu H, Shao L, Zhu D, Chen YW. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton 1999; 43:269-287; PMID:10423269; http://dx.doi.org/10.1002/(SICI)1097-0169(1999)43:4,269::AID-CM1.3.0.CO;2-5
14. Cowland JB, Hother C, Grønbaek K. MicroRNAs and cancer. APMIS 2007; 115:1090-10106; PMID: 18042145; http://dx.doi.org/10.1111/j.1600-0463.2007.apm_775.xml.x
15. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10:1957-1966; PMID:15525708; http://dx.doi.org/10.1261/rna.7135204
16. Salzman DW, Shubert-Coleman J, Furneaux H. P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression. J Biol Chem 2007; 282:32773-32779; PMID:17724023; http://dx.doi.org/10.1074/jbc.M705054200
17. Cullen BR. Derivation and function of small interfering RNAs and microRNAs. Virus Res 2004; 102:3-9; PMID:15068874; http://dx.doi.org/10.1016/j.virusres.2004.01.009
18. Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer 2009; 125:1407-1413; PMID:19536818; http://dx.doi.org/10.1002/ijc.24522
19. Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, et al. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 2010; 285:7986-7994; PMID:20075075; http://dx.doi.org/10.1074/jbc.M109.062877
20. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449:682-688; PMID:17898713; http://dx.doi.org/10.1038/nature06174
21. Bourguignon LY, Wong G, Earle C, Krueger K, Spevak CC. Hyaluronan-CD44 interaction promotes c-Srcmediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinaseassociated cytoskeleton activation and breast tumor cell invasion. J Biol Chem 2010; 285:36721-36735; PMID:20843787; http://dx.doi.org/10.1074/jbc.M110.162305
22. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010; 28:341-347; PMID:20351690; http://dx.doi.org/10.1038/nbt.1618
23. Misra S, Ghatak S, Toole BP. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J Biol Chem 2005; 280:20310-20315; PMID:15784621; http://dx.doi.org/10.1074/jbc.M500737200
24. Bourguignon LY, Earle C, Wong G, Spevak CC, Krueger K. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene 2012; 31:149-160; PMID:21685938; http://dx.doi.org/10.1038/onc.2011.222
25. O'Day E, Lal A. MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 2010;12:201; PMID:20346098; http://dx.doi.org/10.1186/bcr2484
26. Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 2009; 219:214-221; PMID:19593777; http://dx.doi.org/10.1002/path.2586
27. Si M-L, Zhu S, Wu H, Lu Z, Wu F, Mo Y-Y. MiR-21- mediated tumor growth. Oncogene 2007; 26:2799-2803; PMID:17072344; http://dx.doi.org/10.1038/sj.onc.1210083
28. Asangani IA, Rasheed SAK, Nikolova DA, Leupold JH, Colburn NH, Post S, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27:2128-2136; PMID:17968323; http://dx.doi.org/10.1038/sj.onc.1210856
29. Bourguignon LY, Spevak CC, Wong G, Xia W, Gilad E. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressorprotein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem 2009; 284:26533-26546; PMID:19633292; http://dx.doi.org/10.1074/jbc.M109.027466
30. Bourguignon LY, Peyrollier K, Xia W, Gilad E. Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem 2008; 283: 17635-17651; PMID:18441325; http://dx.doi.org/10.1074/jbc.M800109200